Mark Baer
7Patents
1h-index
17Co-inventors
44Inventor score
Filing activity: Dec 1, 2008 → Aug 9, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9999662B2 | Influenza vaccine and therapy | Chemistry; Metallurgy | 1 | Active |
| US10080792B2 | Influenza vaccine and therapy | Chemistry; Metallurgy | 1 | Active |
| US9109032B2 | Methods of treating hematological proliferative disorders by targeting EphA3 expressed on aberrant vasculature in bone marrow | Physics | 1 | Active |
| US9045539B2 | Anti-EMR1 antibodies | Chemistry; Metallurgy | 0 | Active |
| US8044181B2 | Antibodies to the PcrV antigen of Pseudomonas aeruginosa | Chemistry; Metallurgy | 0 | Active |
| US11738080B2 | Production of flu vaccine in Myceliophthora thermophila | Chemistry; Metallurgy | 0 | Active |
| US8877191B2 | Antibodies to the PcrV antigen of Pseudomonas aeruginosa | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.